Richard Furie discusses the potential benefits of BIIB059, an antibody that blocks blood dendritic cell antigen 2, in the treatment of systemic lupus erythematosus and the science behind its phase 2 success (4:47).
11-11-2020 | ACR 2020 | Conference coverage | Video